Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDA Orange Book
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Rsd 1235
2. Rsd-1235
3. Rsd1235
4. Vernakalant
1. 748810-28-8
2. Vernakalant Hcl
3. Brinavess
4. Kynapid
5. Vernakalant (hydrochloride)
6. Rsd1235
7. Vernakalant Hydrochloride [usan]
8. Rsd-1235
9. 7g4j1zd9uq
10. (3r)-1-((1r,2r)-2-(2-(3,4-dimethoxyphenyl)ethoxy)cyclohexyl)pyrrolidin-3-ol Hydrochloride
11. Vernakalant Hydrochloride (usan)
12. Rsd 1235
13. Unii-7g4j1zd9uq
14. (3r)-1-[(1r,2r)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]pyrrolidin-3-ol Hydrochloride
15. Schembl439679
16. Chembl2107383
17. Dtxsid30976007
18. (3r)-1-[(1r,2r)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]pyrrolidin-3-ol;hydrochloride
19. Yeb81028
20. Vernakalant Hydrochloride [mi]
21. Cs-0799
22. Mk-6621
23. Vernakalant Hydrochloride [mart.]
24. As-58436
25. Hy-14183
26. Vernakalant Hydrochloride [who-dd]
27. Vernakalant Hydrochloride [ema Epar]
28. C76396
29. D06665
30. A915186
31. Q27268233
32. Rsd1235 Hydrochloride;rsd 1235 Hydrochloride;rsd-1235 Hydrochloride
33. (3r)-1-[(1r,2r)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]-3-pyrrolidinol Hydrochloride
34. 1-{2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl}pyrrolidin-3-ol--hydrogen Chloride (1/1)
35. (3r)-1-[(1r,2r)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]-3-pyrrolidinol Monohydrochloride
36. 3-pyrrolidinol, 1-((1r,2r)-2-(2-(3,4-dimethoxyphenyl)ethoxy)cyclohexyl)-, Hydrochloride, (3r)-
37. 605683-48-5
| Molecular Weight | 385.9 g/mol |
|---|---|
| Molecular Formula | C20H32ClNO4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 7 |
| Exact Mass | 385.2019862 g/mol |
| Monoisotopic Mass | 385.2019862 g/mol |
| Topological Polar Surface Area | 51.2 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 394 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults:
- for non-surgery patients: atrial fibrillation < /= 7 days duration;
- for post-cardiac surgery patients: atrial fibrillation < /= 3 days duration.
C01BG11
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
A Vernakalant Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vernakalant Hydrochloride, including repackagers and relabelers. The FDA regulates Vernakalant Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vernakalant Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Vernakalant Hydrochloride supplier is an individual or a company that provides Vernakalant Hydrochloride active pharmaceutical ingredient (API) or Vernakalant Hydrochloride finished formulations upon request. The Vernakalant Hydrochloride suppliers may include Vernakalant Hydrochloride API manufacturers, exporters, distributors and traders.
Vernakalant Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vernakalant Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vernakalant Hydrochloride GMP manufacturer or Vernakalant Hydrochloride GMP API supplier for your needs.
A Vernakalant Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Vernakalant Hydrochloride's compliance with Vernakalant Hydrochloride specifications and serves as a tool for batch-level quality control.
Vernakalant Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Vernakalant Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vernakalant Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Vernakalant Hydrochloride EP), Vernakalant Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vernakalant Hydrochloride USP).
LOOKING FOR A SUPPLIER?
